Single Dose Crossover Study to Compare the Respiratory Drive After Administration of Belbuca, Oxycodone and Placebo.

NCT03996694 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

19

Enrollment

INDUSTRY

Sponsor class

Conditions

Respiratory Depression

Interventions

DRUG: Belbuca 300 µg
DRUG: Belbuca 600 µg
DRUG: Belbuca 900 µg
DRUG: Oxycodone 30 mg
DRUG: Oxycodone 60 mg
DRUG: Placebo

Sponsor

BioDelivery Sciences International

Collaborators

[object Object]